We are live on ! Find out more
GLSI icon

Greenwich LifeSciences
GLSI

64 hedge funds and large institutions have $41.1M invested in Greenwich LifeSciences in 2026 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 18 increasing their positions, 12 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 9

50% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 12

48% more capital invested

Capital invested by funds: $27.9M → $41.1M (+$13.3M)

28% more funds holding

Funds holding: 50 → 64 (+14)

2.79% more ownership

Funds ownership: 9.58% → 12.36% (+2.8%)

Holders
64
Holders Change
+14
Holders Change %
+28%
% of All Funds
0.79%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
18
Reduced
12
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
N
Nuveen
North Carolina
+$2.31M
2
BlackRock
BlackRock
New York
+$1.63M
3
Russell Investments Group
Russell Investments Group
United Kingdom
+$1.02M
4
AA
Ancora Advisors
Ohio
+$978K
5
State Street
State Street
Massachusetts
+$942K

Top Sellers

Rank Fund Capital Flow
1
Credit Agricole
Credit Agricole
France
-$1.83M
2
VF
Virtu Financial
New York
-$605K
3
Man Group
Man Group
United Kingdom
-$590K
4
Citadel Advisors
Citadel Advisors
Florida
-$249K
5
Barclays
Barclays
United Kingdom
-$224K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$10.4M +$1.63M +62,396 +17%
VCM
2
Vanguard Capital Management
Pennsylvania
$7.16M +$7.78M +298,266 New
Geode Capital Management
3
Geode Capital Management
Massachusetts
$3.74M +$98.6K +3,782 +2%
State Street
4
State Street
Massachusetts
$3.22M +$942K +36,098 +37%
N
5
Nuveen
North Carolina
$2.13M +$2.31M +88,717 New
Northern Trust
6
Northern Trust
Illinois
$1.8M +$55.2K +2,116 +3%
VPM
7
Vanguard Portfolio Management
Pennsylvania
$1.42M +$1.54M +58,911 New
Bank of New York Mellon
8
Bank of New York Mellon
New York
$1.12M +$852K +32,657 +236%
VFT
9
Vanguard Fiduciary Trust
Pennsylvania
$1.08M +$1.17M +44,908 New
Russell Investments Group
10
Russell Investments Group
United Kingdom
$954K +$1.02M +39,137 +6,989%
Goldman Sachs
11
Goldman Sachs
New York
$949K +$469K +17,976 +83%
AA
12
Ancora Advisors
Ohio
$901K +$978K +37,500 New
Morgan Stanley
13
Morgan Stanley
New York
$716K +$89.9K +3,448 +13%
SEI Investments
14
SEI Investments
Pennsylvania
$627K +$680K +26,088 New
Marshall Wace
15
Marshall Wace
United Kingdom
$616K +$669K +25,658 New
EI
16
EAM Investors
California
$515K +$559K +21,430 New
UBS Group
17
UBS Group
Switzerland
$507K +$392K +15,036 +247%
State of Wisconsin Investment Board
18
State of Wisconsin Investment Board
Wisconsin
$489K +$530K +20,339 New
Millennium Management
19
Millennium Management
New York
$418K +$454K +17,398 New
Charles Schwab
20
Charles Schwab
California
$399K -$63.6K -2,438 -13%
SO
21
STRS Ohio
Ohio
$329K +$209K +8,000 +140%
VGA
22
Vanguard Global Advisers
Pennsylvania
$248K +$270K +10,335 New
Raymond James Financial
23
Raymond James Financial
Florida
$236K +$257K +9,837 New
RhumbLine Advisers
24
RhumbLine Advisers
Massachusetts
$193K -$1.04K -40 -0.5%
Deutsche Bank
25
Deutsche Bank
Germany
$124K -$23.2K -889 -15%
1
2 3

GLSI Hedge Fund Activity: Q1 2026 in Review

64 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in Greenwich LifeSciences (GLSI) for Q1 2026, worth a combined $41.1M — up 48% from $27.9M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new GLSI positions and 9 closed out — a net gain of 15 holders — while 18 added to existing stakes and 12 trimmed.

The largest buyer was Nuveen, opening a new position worth an estimated $2.31M. The largest seller was Credit Agricole, exiting entirely with an estimated $1.83M sold.

  • 64 institutional investors held Greenwich LifeSciences (GLSI) as of Q1 2026, up from 50 in Q4 2025.
  • Funds reported $41.1M of Greenwich LifeSciences stock for Q1 2026, up 48% quarter-over-quarter.
  • 24 funds opened new Greenwich LifeSciences positions in Q1 2026 and 9 closed out, a net change of +15 holders.
  • The largest Greenwich LifeSciences buyer in Q1 2026 was Nuveen, an estimated $2.31M added.
  • The largest Greenwich LifeSciences seller in Q1 2026 was Credit Agricole, an estimated $1.83M sold.

Based on aggregated 13F filings for Q1 2026.